tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

YMAB Stock Latest News

YMAB Earnings this Week: How Will it Perform?
Pre-EarningsYMAB Earnings this Week: How Will it Perform?
4d ago
YMAB
Y-mAbs Therapeutics presents translational pharmacokinetics data of GD2-SADA
PremiumThe Fly
Y-mAbs Therapeutics presents translational pharmacokinetics data of GD2-SADA
22d ago
YMAB
Y-mAbs Therapeutics Updates on Business and Clinical Trials
PremiumCompany Announcements
Y-mAbs Therapeutics Updates on Business and Clinical Trials
1M ago
8K
YMAB
Y-mAbs Therapeutics Announces Strategic Business Realignment
PremiumCompany Announcements
Y-mAbs Therapeutics Announces Strategic Business Realignment
1M ago
8K
YMAB
Y-mAbs Therapeutics appoints Gentilcore as SVP, head of DANYELZA unit
PremiumThe Fly
Y-mAbs Therapeutics appoints Gentilcore as SVP, head of DANYELZA unit
1M ago
YMAB
Y-mAbs Therapeutics announces milestones for 2025
PremiumThe FlyY-mAbs Therapeutics announces milestones for 2025
1M ago
YMAB
Y-mAbs Therapeutics reports preliminary FY24 revenue $88M, consensus $88.53M
Premium
The Fly
Y-mAbs Therapeutics reports preliminary FY24 revenue $88M, consensus $88.53M
1M ago
YMAB
Y-mAbs Therapeutics price target lowered to $14 from $17 at BofA
Premium
The Fly
Y-mAbs Therapeutics price target lowered to $14 from $17 at BofA
2M ago
YMAB
Oppenheimer Predicts Up to ~580% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Up to ~580% Jump for These 2 ‘Strong Buy’ Stocks
2M ago
SGMT
YMAB
Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential
PremiumThe Fly
Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential
3M ago
UTHR
YMAB
Y-mAbs Therapeutics initiated with a Buy at Brookline
PremiumThe Fly
Y-mAbs Therapeutics initiated with a Buy at Brookline
3M ago
YMAB
Y-mAbs Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
Y-mAbs Therapeutics initiated with an Outperform at Oppenheimer
3M ago
YMAB
Y-mAbs Reports Third Quarter 2024 Financial Results
PremiumCompany AnnouncementsY-mAbs Reports Third Quarter 2024 Financial Results
4M ago
YMAB
Morning Movers: Expedia, Airbnb moving in opposite directions after results
Premium
The Fly
Morning Movers: Expedia, Airbnb moving in opposite directions after results
4M ago
FLR
GHM
Y-mAbs Therapeutics reports Q3 EPS (16c), consensus (16c)
Premium
The Fly
Y-mAbs Therapeutics reports Q3 EPS (16c), consensus (16c)
4M ago
YMAB
Y-mAbs Therapeutics backs FY24 revenue view $87M-$95M, consensus $91.67M
PremiumThe Fly
Y-mAbs Therapeutics backs FY24 revenue view $87M-$95M, consensus $91.67M
4M ago
YMAB
Is YMAB a Buy, Before Earnings?
PremiumPre-Earnings
Is YMAB a Buy, Before Earnings?
4M ago
YMAB
Y-mAbs Partners with Nobelpharma for Japan Expansion
PremiumCompany Announcements
Y-mAbs Partners with Nobelpharma for Japan Expansion
4M ago
8K
YMAB
Y-mAbs, Nobelpharma announce exclusive license, distribution agreement
PremiumThe Fly
Y-mAbs, Nobelpharma announce exclusive license, distribution agreement
4M ago
YMAB
Y-mAbs Therapeutics announces new data on naxitamab, GD2-SADA
PremiumThe FlyY-mAbs Therapeutics announces new data on naxitamab, GD2-SADA
6M ago
YMAB
Cisco, Nike upgrades among today’s top calls on Wall Street
Premium
The Fly
Cisco, Nike upgrades among today’s top calls on Wall Street
6M ago
EL
JD
Cantor starts Y-mAbs with Overweight on pivot to radiopharmaceuticals
Premium
The Fly
Cantor starts Y-mAbs with Overweight on pivot to radiopharmaceuticals
6M ago
YMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >